Food Science and Technology
http://www.fst.periodikos.com.br/journal/fst/article/doi/10.1590/1678-457X.26216
Food Science and Technology
Research Paper

Synbiotic preparation with Lactic acid bacteria and inulin as a functional food: In vivo evaluation of microbial activities, and preneoplastic aberrant crypt foci

Chaiyavat CHAIYASUT; Thanawat PATTANANANDECHA; Sasithorn SIRILUN; Prasit SUWANNALERT; Sartjin PEERAJAN; Bhagavathi Sundaram SIVAMARUTHI

Abstract

Abstract: Host microbiome and metabolome are associated with the incidence of colorectal cancer (CC), one of the major health problems in developed countries. The pro and prebiotic supplementation helps to improve the host health. Inulin is one such prebiotic used for the enhancement of naïve probiotic bacterial population. This paper explains the impact of inulin (PRE) extracted from Jerusalem artichoke (JA), Lactobacillus plantarum HII11 (PRO), and synbiotic (SYN; inulin + L. plantarum HII11) preparation on Azoxymethane mediated CC induced rat model with respect to changes in microbial load, microbial enzymes, and preneoplastic aberrant crypt foci. The results suggested that the PRE and SYN supplementation effectively reduced the selected pathogenic bacteria (Salmonella spp., and Escherichia coli), microbial enzymes and increased the probiotic load. The intervention of SYN significantly reduced the colonic ACF in CC model. The study results revealed that the supplementation of SYN diet (inulin and L. plantarum HII11) protects the AOM-mediated colon cancer induced host.

Keywords

inulin, L. plantarum, probiotic, prebiotic, synbiotic

References

Anandharaj, M., Sivasankari, B., & Parveen Rani, R. (2014). Effects of probiotics, prebiotics, and synbiotics on hypercholesterolemia: a review. Chinese Journal of Biology, 2014, 1-7. http://dx.doi.org/10.1155/2014/572754.

Arimochi, H., Kinouchi, T., Kataoka, K., Kuwahara, T., & Ohnishi, Y. (1997). Effect of intestinal bacteria on formation of azoxymethane-induced aberrant crypt foci in the rat colon. Biochemical and Biophysical Research Communications, 238(3), 753-757. PMid:9325162. http://dx.doi.org/10.1006/bbrc.1997.7384.

Burns, A. J., & Rowland, I. R. (2000). Anti-carcinogenicity of probiotics and prebiotics. Current Issues in Intestinal Microbiology, 1(1), 13-24. PMid:11709850.

Callaway, T. R., Edrington, T. S., Harvey, R. B., Anderson, R. C., & Nisbet, D. J. (2012). Prebiotics in food animals, a potential to reduce foodborne pathogens and disease. Romanian Biotechnological Letters, 17, 7808-7816.

Center, M. M., Jemal, A., & Ward, E. (2009). International trends in colorectal cancer incidence rates. Cancer Epidemiology, Biomarkers & Prevention, 18(6), 1688-1694. PMid:19505900. http://dx.doi.org/10.1158/1055-9965.EPI-09-0090.

Cerini, C., Dou, L., Anfosso, F., Sabatier, F., Moal, V., Glorieux, G., De Smet, R., Vanholder, R., Dignat-George, F., Sampol, J., Berland, Y., & Brunet, P. (2004). P-cresol, a uremic retention solute, alters the endothelial barrier function in vitro. Thrombosis and Haemostasis, 92(1), 140-150. PMid:15213855.

Chan, D. S., Lau, R., Aune, D., Vieira, R., Greenwood, D. C., Kampman, E., & Norat, T. (2011). Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS One, 6(6), e20456. PMid:21674008. http://dx.doi.org/10.1371/journal.pone.0020456.

Comalada, M., Bailon, E., de Haro, O., Lara-Villoslada, F., Xaus, J., Zarzuelo, A., & Gálvez, J. (2006). The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype. Journal of Cancer Research and Clinical Oncology, 132(8), 487-497. PMid:16788843. http://dx.doi.org/10.1007/s00432-006-0092-x.

Cummings, J. H., Macfarlane, G. T., & Englyst, H. N. (2001). Prebiotic digestion and fermentation. The American Journal of Clinical Nutrition, 73(2, Suppl), 415S-420S. PMid:11157351.

De Preter, V., Vanhoutte, T., Huys, G., Swings, J., De Vuyst, L., Rutgeerts, P., & Verbeke, K. (2007a). Effects of , and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans. Lactobacillus casei Shirota, Bifidobacterium breveAmerican Journal of Physiology. Gastrointestinal and Liver Physiology, 292(1), G358-G368. PMid:16990449. http://dx.doi.org/10.1152/ajpgi.00052.2006.

De Preter, V., Raemen, H., Cloetens, L., Houben, E., Rutgeerts, P., & Verbeke, K. (2007b). Effect of dietary intervention with different pre- and probiotics on intestinal bacterial enzyme activities. European Journal of Clinical Nutrition, 62(2), 225-231. PMid:17327863. http://dx.doi.org/10.1038/sj.ejcn.1602706.

Femia, A. P., Luceri, C., Dolara, P., Giannini, A., Biggeri, A., Salvadori, M., Clune, Y., Collins, K. J., Paglierani, M., & Caderni, G. (2002). Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics and on azoxymethane-induced colon carcinogenesis in rats. Lactobacillus rhamnosusBifidobacterium lactisCarcinogenesis, 23(11), 1953-1960. PMid:12419846. http://dx.doi.org/10.1093/carcin/23.11.1953.

Fung, K. Y., Brierley, G. V., Henderson, S., Hoffmann, P., McColl, S. R., Lockett, T., Head, R., & Cosgrove, L. (2011). Butyrate-induced apoptosis in HCT116 colorectal cancer cells includes induction of a cell stress response. Journal of Proteome Research, 10(4), 1860-1869. PMid:21235278. http://dx.doi.org/10.1021/pr1011125.

Gibson, G. R., Scott, K. P., Rastall, R. A., Tuohy, K. M., Hotchkiss, A., Dubert-Ferrandon, A., Gareau, M., Murphy, E. F., Saulnier, D., Loh, G., Macfarlane, S., Delzenne, N., Ringel, Y., Kozianowski, G., Dickmann, R., Lenoir-Wijnkoop, I., Walker, C., & Buddington, R. (2010). Dietary prebiotics: current status and new definition. Food Science and Technology Bulletin, 7(1), 1-19. http://dx.doi.org/10.1616/1476-2137.15880.

Gmeiner, M., Kneifel, W., Kulbe, K. D., Wouters, R., De Boever, P., Nollet, L., & Verstraete, W. (2000). Influence of a synbiotic mixture consisting of Lactobacillus acidophilus 74-2 and a fructo-oligosaccharide preparation on the microbial ecology sustained in a simulation of the human intestinal microbial ecosystem (SHIME reactor). Applied Microbiology and Biotechnology, 53(2), 219-223. PMid:10709985. http://dx.doi.org/10.1007/s002530050011.

Guinane, C. M., & Cotter, P. D. (2013). Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therapeutic Advances in Gastroenterology, 6(4), 295-308. PMid:23814609. http://dx.doi.org/10.1177/1756283X13482996.

Hijova, E., Szabadosova, V., Strojny, L., & Bomba, A. (2014). Changes chemopreventive markers in colorectal cancer development after inulin supplementation. Bratislavske Lekarske Listy, 115(2), 76-79. PMid:24601699.

Hirschhaeuser, F., Sattler, U. G., & Mueller-Klieser, W. (2011). Lactate: a metabolic key player in cancer. Cancer Research, 71(22), 6921-6925. PMid:22084445. http://dx.doi.org/10.1158/0008-5472.CAN-11-1457.

Hosseini, E., Grootaert, C., Verstraete, W., & Van de Wiele, T. (2011). Propionate as a health-promoting microbial metabolite in the human gut. Nurture Review, 69(5), 245-258. PMid:21521227. http://dx.doi.org/10.1111/j.1753-4887.2011.00388.x.

Hughes, R., & Rowland, I. R. (2000). Metabolic activities of the gut microflora in relation to cancer. Microbial Ecology in Health and Disease, 12(2), 179-185. http://dx.doi.org/10.1080/089106000750060431.

Hughes, R., Magee, E. A., & Bingham, S. (2000). Protein degradation in the large intestine: relevance to colorectal cancer. Current Issues in Intestinal Microbiology, 1(2), 51-58. PMid:11709869.

Huxley, R. R., Ansary-Moghaddam, A., Clifton, P., Czernichow, S., Parr, C. L., & Woodward, M. (2009). The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. International Journal of Cancer, 125(1), 171-180. PMid:19350627. http://dx.doi.org/10.1002/ijc.24343.

Iannitti, T., & Palmieri, B. (2010). Therapeutical use of probiotic formulations in clinical practice. Clinical Nutrition, 29(6), 701-725. PMid:20576332. http://dx.doi.org/10.1016/j.clnu.2010.05.004.

Kolida, S., & Gibson, G. R. (2011). Synbiotics in health and disease. Annual Review of Food Science and Technology, 2(1), 373-393. PMid:22129388. http://dx.doi.org/10.1146/annurev-food-022510-133739.

Kolida, S., Tuohy, K., & Gibson, G. R. (2002). Prebiotic effects of inulin and oligofructose. British Journal of Nutrition, 87(2, Suppl 2), S193-S197. PMid:12088518. http://dx.doi.org/10.1079/BJN/2002537.

Le Leu, R. K., Brown, I. L., Hu, Y., & Young, G. P. (2003). Effect of resistant starch on genotoxin-induced apoptosis, colonic epithelium, and lumenal contents in rats. Carcinogenesis, 24(8), 1347-1352. PMid:12807738. http://dx.doi.org/10.1093/carcin/bgg098.

Le Leu, R. K., Brown, I. L., Hu, Y., Morita, T., Esterman, A., & Young, G. P. (2007). Effect of dietary resistant starch and protein on colonic fermentation and intestinal tumourigenesis in rats. Carcinogenesis, 28(2), 240-245. PMid:17166881. http://dx.doi.org/10.1093/carcin/bgl245.

Le Leu, R., Hu, Y., Brown, I., Woodman, R., & Young, G. (2010). Synbiotic intervention . of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in ratsCarcinogenesis, 31(2), 246-251. PMid:19696163. http://dx.doi.org/10.1093/carcin/bgp197.

Lee, S. M., & Lee, W. K. (2011). Effects of lactic acid bacteria on intestinal microbial enzyme activity and composition in rats treated with azoxymethane. Journal of Microbiology, 39, 154-161.

Liong, M. T. (2008). Roles of probiotics and prebiotics in colon cancer prevention: postulated mechanisms and in vivo evidence. International Journal of Molecular Sciences, 9(5), 854-863. PMid:19325789. http://dx.doi.org/10.3390/ijms9050854.

Louis, P., Hold, G. L., & Flint, H. J. (2014). The gut microbiota, bacterial metabolites and colorectal cancer. Nature Reviews. Microbiology, 12(10), 661-672. PMid:25198138. http://dx.doi.org/10.1038/nrmicro3344.

McCall, I. C., Betanzos, A., Weber, D. A., Nava, P., Miller, G. W., & Parkos, C. A. (2009). Effects of phenol on barrier function of a human intestinal epithelial cell line correlate with altered tight junction protein localization. Toxicology and Applied Pharmacology, 241(1), 61-70. PMid:19679145. http://dx.doi.org/10.1016/j.taap.2009.08.002.

Moreno de LeBlanc, A., & Perdigón, G. (2005). Reduction of beta-glucuronidase and nitroreductase activity by yoghurt in a murine colon cancer model. Biocell, 29(1), 15-24. PMid:15954463.

Noack, J., Timm, D., Hospattankar, A., & Slavin, J. (2013). Fermentation profiles of wheat dextrin, inulin and partially hydrolyzed guar gum using an in vitro digestion pretreatment and batch fermentation system model. in vitroNutrients, 5(5), 1500-1510. PMid:23645025. http://dx.doi.org/10.3390/nu5051500.

Nowak, A., & Libudzisz, Z. (2006). Influence of phenol, p-cresol and indole on growth and survival of intestinal lactic acid bacteria. Anaerobe, 12(2), 80-84. PMid:16701619. http://dx.doi.org/10.1016/j.anaerobe.2005.10.003.

Ochiai, M., Hippo, Y., Izumiya, M., Watanabe, M., & Nakagama, H. (2014). Newly defined aberrant crypt foci as a marker for dysplasia in the rat colon. Cancer Science, 105(8), 943-950. PMid:24827115. http://dx.doi.org/10.1111/cas.12446.

Ohtani, N. (2015). Microbiome and cancer. Seminars in Immunopathology, 37(1), 65-72. PMid:25404117. http://dx.doi.org/10.1007/s00281-014-0457-1.

Ouwehand, A. C., Lagstrom, H., Suomalainen, T., & Salminen, S. (2002). Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Annals of Nutrition & Metabolism, 46(3-4), 159-162. PMid:12169860. http://dx.doi.org/10.1159/000063075.

Pan, X., Chen, F., Wu, T., Tang, H., & Zhao, Z. (2009). Prebiotic oligosaccharides change the concentrations of short-chain fatty acids and the microbial population of mouse bowel. Journal of Zhejiang University. Science. B., 10(4), 258-263. PMid:19353743. http://dx.doi.org/10.1631/jzus.B0820261.

Pattananandecha, T., Sirilun, S., Duangjitcharoen, Y., Sivamaruthi, B. S., Suwannalert, P., Peerajan, S., & Chaiyasut, C. (2016). Hydrolyzed inulin alleviates the azoxymethane-induced preneoplastic aberrant crypt foci by altering selected intestinal microbiota in Sprague-Dawley rats. Pharmaceutical Biology, 54(9), 1596-1605. PMid:26794346. http://dx.doi.org/10.3109/13880209.2015.1110597.

Pattananandecha, T., Sirilun, S., Sivamaruthi, B. S., Suwannalert, P., Peerajan, S., & Chaiyasut, C. (2015). Hydrolyzed Inulin with Different Degree of Polymerization as Prebiotic for Lactobacillus plantarum.Journal of Pure & Applied Microbiology, 9(2), 973-979.

Pool-Zobel, B. L., Selvaraju, V., Sauer, J., Kautenburger, T., Kiefer, J., Richter, K. K., Soom, M., & Wölfl, S. (2005). Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S-transferases genes, an approach in nutrigenomics. Carcinogenesis, 26(6), 1064-1076. PMid:15746163. http://dx.doi.org/10.1093/carcin/bgi059.

Pourhoseingholi, M. A. (2012). Increased burden of colorectal cancer in Asia. World Journal of Gastrointestinal Oncology, 4(4), 68-70. PMid:22532878. http://dx.doi.org/10.4251/wjgo.v4.i4.68.

Propst, E. L., Flickinger, E. A., Bauer, L. L., Merchen, N. R., & Fahey, G. C. Jr (2003). A dose-response experiment evaluating the effects of oligofructose and inulin on nutrient digestibility, stool quality, and fecal protein catabolites in healthy adult dogs. Journal of Animal Science, 81(12), 3057-3066. PMid:14677862. http://dx.doi.org/10.2527/2003.81123057x.

Rafii, F., Franklin, W., & Cerniglia, C. E. (1990). Azoreductase activity of anaerobic bacteria isolated from human intestinal microflora. Applied and Environmental Microbiology, 56(7), 2146-2151. PMid:2202258.

Raman, M., Ambalam, P., Kondepudi, K. K., Pithva, S., Kothari, C., Patel, A. T., Purama, R. K., Dave, J. M., & Vyas, B. R. (2013). Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer. Gut Microbes, 4(3), 181-192. PMid:23511582. http://dx.doi.org/10.4161/gmic.23919.

Reddy, B., Hamid, R., & Rao, C. V. (1997). Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis, 18(7), 1371-1374. PMid:9230282. http://dx.doi.org/10.1093/carcin/18.7.1371.

Riboli, E., & Norat, T. (2003). Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. The American Journal of Clinical Nutrition, 78(3, Suppl), 559s-569s. PMid:12936950.

Rossi, M., Corradini, C., Amaretti, A., Nicolini, M., Pompei, A., Zanoni, S., & Matteuzzi, D. (2005). Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal cultures. Applied and Environmental Microbiology, 71(10), 6150-6158. PMid:16204533. http://dx.doi.org/10.1128/AEM.71.10.6150-6158.2005.

Rowland, I., Rumney, C., Coutts, J., & Lievense, L. (1998). Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis, 19(2), 281-285. PMid:9498277. http://dx.doi.org/10.1093/carcin/19.2.281.

Ruemmele, F. M., Schwartz, S., Seidman, E. G., Dionne, S., Levy, E., & Lentze, M. J. (2003). Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut, 52(1), 94-100. PMid:12477768. http://dx.doi.org/10.1136/gut.52.1.94.

Schwabe, R. F., & Jobin, C. (2013). The microbiome and cancer. Nature Reviews. Cancer, 13(11), 800-812. PMid:24132111. http://dx.doi.org/10.1038/nrc3610.

Siavoshian, S., Segain, J., Kornprobst, M., Bonnet, C., Cherbut, C., Galmiche, J., & Blottiere, H. (2000). Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut, 46(4), 507-514. PMid:10716680. http://dx.doi.org/10.1136/gut.46.4.507.

Slavin, J. (2013). Fiber and prebiotics: mechanisms and health benefits. Nutrients, 5(4), 1417-1435. PMid:23609775. http://dx.doi.org/10.3390/nu5041417.

Swanson, K. S., Grieshop, C. M., Flickinger, E. A., Bauer, L. L., Healy, H. P., Dawson, K. A., Merchen, N. R., & Fahey, G. C. Jr (2002). Supplemental fructo-oligosaccharides and mannan-oligosaccharides influence immune function, ileal and total tract nutrient digestibilities, microbial populations and concentrations of protein catabolites in the large bowel of dogs. The Journal of Nutrition, 132(5), 980-989. PMid:11983825.

Uccello, M., Malaguarnera, G., Basile, F., D’agata, V., Malaguarnera, M., Bertino, G., Vacante, M., Drago, F., & Biondi, A. (2012). Potential role of probiotics on colorectal cancer prevention. BMC Surgery, 12(Suppl 1), S35. PMid:23173670. http://dx.doi.org/10.1186/1471-2482-12-S1-S35.

Van, M. H. M. C., Meyer, P. D., & Venema, K. (2003). The effect of various inulins and on the metabolic activity of the human colonic microbiota Clostridium difficilein vitro.Microbial Ecology in Health and Disease, 15(2-3), 137-144. http://dx.doi.org/10.1080/08910600310018959.

Waldecker, M., Kautenburger, T., Daumann, H., Busch, C., & Schrenk, D. (2008). Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. The Journal of Nutritional Biochemistry, 19(9), 587-593. PMid:18061431. http://dx.doi.org/10.1016/j.jnutbio.2007.08.002.

Windey, K., De Preter, V., & Verbeke, K. (2012). Relevance of protein fermentation to gut health. Molecular Nutrition & Food Research, 56(1), 184-196. PMid:22121108. http://dx.doi.org/10.1002/mnfr.201100542.

Wollowski, I., Rechkemmer, G., & Pool-Zobel, B. L. (2001). Protective role of probiotics and prebiotics in colon cancer. The American Journal of Clinical Nutrition, 73(2, Suppl), 451s-455s. PMid:11157356.

Yoon, H., Benamouzig, R., Little, J., François-Collange, M., & Tomé, D. (2000). Systematic review of epidemiological studies on meat, dairy products and egg consumption and risk of colorectal adenomas. European Journal of Cancer Prevention, 9(3), 151-164. PMid:10954254. http://dx.doi.org/10.1097/00008469-200006000-00002.
 

593042450e8825cc13e07153 fst Articles

Food Sci. Technol.

Share this page
Page Sections